Zhuhui Ge1,2, Jianhua Mao3, Huijun Shen1, Yu Xu4, Haidong Fu1, Weiwei Zhang2, Dongyan Li1. 1. Department of Nephrology, the Children's Hospital, Zhejiang University School of Medicine, 3333 Binsheng Road, Hangzhou, China. 2. Department of Pediatrics, the Frist Hospital of Ninghai, 142 Taoyuan Middle Road, Ninghai County, Zhejiang Province, China. 3. Department of Nephrology, the Children's Hospital, Zhejiang University School of Medicine, 3333 Binsheng Road, Hangzhou, China. maojh88@zju.edu.cn. 4. Department of Hematology, the People's Hospital of Ruian, 108 Wansong Road, Rui 'an City, Zhejiang Province, China.
Abstract
BACKGROUND: Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a rare autosomal recessive lysosomal storage disorder. Up to now, reports on the clinical characteristics of MPS IVA mainly focused on patients with progressive bone dysplasia and multiple organ damage, while the effects of this disorder on neurogenic bladder have not been reported. Therefore, the aim of the present study is to report two cases of nocturnal enuresis finally diagnosed as neurogenic bladder in MPS IVA. CASE PRESENTATION: Both children were characterized by the presence of pectus carinatum, kyphoscoliosis, nocturnal enuresis, urinary incontinence, normal intelligence, and loss of strength in the legs, diagnosed as neurogenic bladder in association with MPS IVA through the analysis of the clinical characteristics, enzyme activity and genetic testing. In addition, the terminator codon mutation c.1567T > G (p.X523E) and a novel missense mutation c.575A > G (p.E192G) were found in the coding region of the GALNS gene of the 1st patient, while the missense mutation c.488C > A (p.P163H) was found in the coding region of the GALNS gene of the 2nd patient. CONCLUSIONS: Neurogenic bladder may occur in patients with MPS IVA after spinal cord injury. It is necessary to screen for the diagnosis of MPS IVA in patients with atypical enuresis and skeletal abnormalities through the analysis of the clinical characteristics, enzyme activity and genetic testing.
BACKGROUND:Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a rare autosomal recessive lysosomal storage disorder. Up to now, reports on the clinical characteristics of MPS IVA mainly focused on patients with progressive bone dysplasia and multiple organ damage, while the effects of this disorder on neurogenic bladder have not been reported. Therefore, the aim of the present study is to report two cases of nocturnal enuresis finally diagnosed as neurogenic bladder in MPS IVA. CASE PRESENTATION: Both children were characterized by the presence of pectus carinatum, kyphoscoliosis, nocturnal enuresis, urinary incontinence, normal intelligence, and loss of strength in the legs, diagnosed as neurogenic bladder in association with MPS IVA through the analysis of the clinical characteristics, enzyme activity and genetic testing. In addition, the terminator codon mutation c.1567T > G (p.X523E) and a novel missense mutation c.575A > G (p.E192G) were found in the coding region of the GALNS gene of the 1st patient, while the missense mutation c.488C > A (p.P163H) was found in the coding region of the GALNS gene of the 2nd patient. CONCLUSIONS:Neurogenic bladder may occur in patients with MPS IVA after spinal cord injury. It is necessary to screen for the diagnosis of MPS IVA in patients with atypical enuresis and skeletal abnormalities through the analysis of the clinical characteristics, enzyme activity and genetic testing.
Authors: S Tomatsu; T Nishioka; A M Montaño; M A Gutierrez; O S Pena; K O Orii; W S Sly; S Yamaguchi; T Orii; E Paschke; S G Kircher; A Noguchi Journal: J Med Genet Date: 2004-07 Impact factor: 6.318
Authors: E Salvaggio; D Antuzzi; P Ferrara; M Scanu; S Pulitanò; L Venuti; E Tarquini; T De Michele; R Ricci Journal: Urol Int Date: 2001 Impact factor: 2.089
Authors: Shunji Tomatsu; Mirella Filocamo; Koji O Orii; William S Sly; Monica A Gutierrez; Tatsuo Nishioka; Olga Peña Serrato; Paola Di Natale; Adriana Maria Montaño; Seiji Yamaguchi; Naomi Kondo; Tadao Orii; Akihiko Noguchi Journal: Hum Mutat Date: 2004-08 Impact factor: 4.878
Authors: Jorge Luis Suarez-Guerrero; Pedro José Iván Gómez Higuera; Juan Sebastian Arias Flórez; Gustavo Adolfo Contreras-García Journal: Rev Chil Pediatr Date: 2015-11-21
Authors: C J Hendriksz; P Harmatz; M Beck; S Jones; T Wood; R Lachman; C G Gravance; T Orii; S Tomatsu Journal: Mol Genet Metab Date: 2013-04-10 Impact factor: 4.797